Evidence map›Paper›PMID 25071349›Full record

ArticleWorld journal of gastroenterology2014

Postprandial response of bone turnover markers in patients with Crohn's disease.

Ioannis Karatzoglou, Maria P Yavropoulou, Maria Pikilidou, George Germanidis, Evangelos Akriviadis, Alexandra Papazisi, Michael Daniilidis, Pantelis Zebekakis, John G Yovos

Open access · hybridAbstract read
In one paragraph

Article in World journal of gastroenterology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 9 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Use of CTX-I and PINP as bone turnover markers: National Bone Health Alliance recommendations to standardize sample handling and patient preparation to reduce pre-analytical variability.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Ioannis KaratzoglouIoannis Karatzoglou, Maria Pikilidou, George Germanidis, Michael Daniilidis, Pantelis Zebekakis, 1 Department of Internal Medicine, AHEPA University Hospital, Aristotle University of Thessaloniki, 54636 Thessaloniki, Greece.
Maria P YavropoulouIoannis Karatzoglou, Maria Pikilidou, George Germanidis, Michael Daniilidis, Pantelis Zebekakis, 1 Department of Internal Medicine, AHEPA University Hospital, Aristotle University of Thessaloniki, 54636 Thessaloniki, Greece.
Maria PikilidouIoannis Karatzoglou, Maria Pikilidou, George Germanidis, Michael Daniilidis, Pantelis Zebekakis, 1 Department of Internal Medicine, AHEPA University Hospital, Aristotle University of Thessaloniki, 54636 Thessaloniki, Greece.
George GermanidisIoannis Karatzoglou, Maria Pikilidou, George Germanidis, Michael Daniilidis, Pantelis Zebekakis, 1 Department of Internal Medicine, AHEPA University Hospital, Aristotle University of Thessaloniki, 54636 Thessaloniki, Greece.
Evangelos AkriviadisIoannis Karatzoglou, Maria Pikilidou, George Germanidis, Michael Daniilidis, Pantelis Zebekakis, 1 Department of Internal Medicine, AHEPA University Hospital, Aristotle University of Thessaloniki, 54636 Thessaloniki, Greece.
Alexandra PapazisiIoannis Karatzoglou, Maria Pikilidou, George Germanidis, Michael Daniilidis, Pantelis Zebekakis, 1 Department of Internal Medicine, AHEPA University Hospital, Aristotle University of Thessaloniki, 54636 Thessaloniki, Greece.
Michael DaniilidisIoannis Karatzoglou, Maria Pikilidou, George Germanidis, Michael Daniilidis, Pantelis Zebekakis, 1 Department of Internal Medicine, AHEPA University Hospital, Aristotle University of Thessaloniki, 54636 Thessaloniki, Greece.
Pantelis ZebekakisIoannis Karatzoglou, Maria Pikilidou, George Germanidis, Michael Daniilidis, Pantelis Zebekakis, 1 Department of Internal Medicine, AHEPA University Hospital, Aristotle University of Thessaloniki, 54636 Thessaloniki, Greece.
John G YovosIoannis Karatzoglou, Maria Pikilidou, George Germanidis, Michael Daniilidis, Pantelis Zebekakis, 1 Department of Internal Medicine, AHEPA University Hospital, Aristotle University of Thessaloniki, 54636 Thessaloniki, Greece.
AHEPA University Hospital · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimTo investigate the postprandial response of bone turnover markers in patients with Crohn's disease (CD).

methodsFifty nine patients with CD aged 38 ± 14 years, and 45 healthy individuals matched for age and body mass index were included in the study. All participants underwent an oral glucose tolerance test (OGTT) after an overnight fast and serum levels of the bone resorption marker C-terminal crosslinking telopeptide of type I collagen (CTX-I) and the bone formation marker procollagen type I N propeptide were measured. Activity of the disease was assessed by calculation of the Crohn's disease activity index (CDAI).

resultsSerum CTX-I was significantly higher in patients compared to controls (CTX-I: 453 ± 21 pg/mL vs 365 ± 25 pg/mL, P = 0.008), and values were significantly correlated with the activity of the disease (r = 0.435, P = 0.001). Results from OGTT-induced suppression of CTX-I showed two different trends. Patients with more active disease (assessed as CDAI > 150) had a more excessive suppression of CTX-I compared to controls (55% vs 43% P < 0.001), while patients on remission (assessed as CDAI < 150) demonstrated an attenuated CTX-I suppression (30% vs 43% P < 0.001). In line with this, CTX-I suppression after oral glucose load was significantly correlated with the activity of the disease (r = 0.913, P < 0.001).

conclusionThe physiological skeletal response of postprandial suppression of bone resorption is maintained in patients with CD and is strongly dependent to the activity of the disease.

Indexed as

Bone RemodelingPostprandial PeriodAdultBiomarkersCase-Control StudiesCollagen Type ICrohn DiseaseDown-RegulationFemaleGlucose Tolerance TestHumansMaleMiddle AgedPeptide FragmentsPeptidesProcollagenBiomarkersCollagen Type Icollagen type I trimeric cross-linked peptidePeptide FragmentsPeptidesProcollagenprocollagen Type I N-terminal peptideBone metabolismCrohn’s diseaseC-terminal crosslinking telopeptide of type I collagenOral glucose tolerance testPostprandial bone resorption

Identifiers

PMID25071349
PMCPMC4110586
OpenAlexW2219131428

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.